ANTICANCER DRUGS
Keywords:
medicine, medicinal product, antitumor agents, anti-blastoma agents, chemotherapy, hormone therapy, photodynamic means, targeted therapy, cytostatic action, cytotoxic action, radiopharmaceuticals, phase specificity, cycle specificity, palliative care, adjuvant treatment, remission induction, maintenance therapy.Abstract
The article presents an overview of anticancer drugs for medical use currently registered in Uzbekistan and at the final stage of their development - clinical trials in accredited testing centers for subsequent registration. The generalized information was obtained from official sources - the State Register of Medicines of the Ministry of Health of Uzbekistan, the Electronic Rubricator of Clinical Recommendations and Clinical Guidelines and orders on the Standards of Medical Care prepared on their basis. The place and role of chemotherapeutic agents in the treatment of oncological patients and typical schemes for the use of antiblastoma agents in the most widespread and most severe nosological forms of tumor diseases are shown.
Downloads
References
Garin A.M., Bazin I.S. Morbidity, mortality, long-term results and consequences of treatment of cancer patients in different countries of the world. Russian journal of oncology. 2016; 21(1-2): 11-7.
Dmitrieva N.B., Kukushkin G.V. Medicines for the treatment of infectious and oncological diseases: a textbook. M.; 2016.
V. I. Chissov and M. I. Davydov, ed. Oncology: National Guide. Moscow: GEOTAR-Media; 2013.
Alyautdin R.N., red. Pharmacology. Moscow: GEOTAR-Media; 2016.
Avdeev S.N., red. Federal Guidelines for the Use of Medicines (Formulary System). Issue XVIII. M.; 2017.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in this journal are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under this license:
- Share: Copy and redistribute the material in any medium or format
- Adapt: Remix, transform, and build upon the material for any purpose, including commercially
Attribution required: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
License URL: https://creativecommons.org/licenses/by/4.0/
Authors retain copyright of their work while granting the journal first publication rights.
